258 related articles for article (PubMed ID: 8315492)
61. Cloned catecholamine transporters expressed in polarized epithelial cells: sorting, drug sensitivity, and ion-coupling stoichiometry.
Gu H; Caplan MJ; Rudnick G
Adv Pharmacol; 1998; 42():175-9. PubMed ID: 9327872
[No Abstract] [Full Text] [Related]
62. Opposing changes in serotonin and norepinephrine transporter mRNA levels after serotonin depletion.
Koed K; Linnet K
Eur Neuropsychopharmacol; 2000 Dec; 10(6):501-9. PubMed ID: 11115741
[TBL] [Abstract][Full Text] [Related]
63. Human norepinephrine transporter kinetics using rotating disk electrode voltammetry.
Burnette WB; Bailey MD; Kukoyi S; Blakely RD; Trowbridge CG; Justice JB
Anal Chem; 1996 Sep; 68(17):2932-8. PubMed ID: 8794928
[TBL] [Abstract][Full Text] [Related]
64. General anesthetic actions on norepinephrine, dopamine, and gamma-aminobutyric acid transporters in stably transfected cells.
Shahani SK; Lingamaneni R; Hemmings HC
Anesth Analg; 2002 Oct; 95(4):893-9, table of contents. PubMed ID: 12351264
[TBL] [Abstract][Full Text] [Related]
65. Baculovirus-mediated expression of neurotransmitter transporters.
Tate CG
Methods Enzymol; 1998; 296():443-55. PubMed ID: 9779466
[No Abstract] [Full Text] [Related]
66. Comparison of MIBG and monoamines uptake mechanisms: pharmacological animal and blood platelets studies.
Guilloteau D; Chalon S; Baulieu JL; Huguet F; Desplanches G; Chambon C; Vilar MP; Pourcelot L; Besnard JC
Eur J Nucl Med; 1988; 14(7-8):341-4. PubMed ID: 3141186
[TBL] [Abstract][Full Text] [Related]
67. Advances in sodium-ion coupled biogenic amine transporters.
Graham D; Langer SZ
Life Sci; 1992; 51(9):631-45. PubMed ID: 1501510
[TBL] [Abstract][Full Text] [Related]
68. Neurotransmission of cognition, part 3. Mechanism of action of selective NRIs: both dopamine and norepinephrine increase in prefrontal cortex.
Stahl SM
J Clin Psychiatry; 2003 Mar; 64(3):230-1. PubMed ID: 12716261
[TBL] [Abstract][Full Text] [Related]
69. Voltammetric studies on kinetics of uptake and efflux at catecholamine transporters.
Danek K; Justice JB
Methods Enzymol; 1998; 296():649-60. PubMed ID: 9779480
[No Abstract] [Full Text] [Related]
70. Neurotransmitter transporters: fruitful targets for CNS drug discovery.
Iversen L
Mol Psychiatry; 2000 Jul; 5(4):357-62. PubMed ID: 10889545
[TBL] [Abstract][Full Text] [Related]
71. In vitro pharmacology of metaiodobenzylguanidine uptake, storage and release in human neuroblastoma cells.
Montaldo PG; Carbone R; Lanciotti M; Ponzoni M; Cornaglia-Ferraris P
J Nucl Biol Med (1991); 1991; 35(4):195-8. PubMed ID: 1823817
[TBL] [Abstract][Full Text] [Related]
72. Molecular cloning and functional expression of the mouse dopamine transporter.
Brüss M; Wieland A; Bönisch H
J Neural Transm (Vienna); 1999; 106(7-8):657-62. PubMed ID: 10907725
[TBL] [Abstract][Full Text] [Related]
73. Regional alterations of myocardial norepinephrine transporter density in streptozotocin-induced diabetic rats: implications for heterogeneous cardiac accumulation of MIBG in diabetes.
Kiyono Y; Iida Y; Kawashima H; Tamaki N; Nishimura H; Saji H
Eur J Nucl Med; 2001 Jul; 28(7):894-9. PubMed ID: 11504086
[TBL] [Abstract][Full Text] [Related]
74. Neurotransmitter transporters: recent progress.
Amara SG; Kuhar MJ
Annu Rev Neurosci; 1993; 16():73-93. PubMed ID: 8096377
[No Abstract] [Full Text] [Related]
75. Neurotransmitter transporters (plus): a promising new gene family.
Uhl GR
Trends Neurosci; 1992 Jul; 15(7):265-8. PubMed ID: 1381123
[TBL] [Abstract][Full Text] [Related]
76. Disposition of radioiodinated benzylguanidines in perfused rabbit lung: pharmacokinetics and effect of an organo-gold complexed antineoplastic agent.
Weng WL; Lazo JS; Gillis CN; Pitt BR
J Pharmacol Exp Ther; 1990 Oct; 255(1):59-65. PubMed ID: 2213571
[TBL] [Abstract][Full Text] [Related]
77. A previously undescribed intron and extensive 5' upstream sequence, but not Phox2a-mediated transactivation, are necessary for high level cell type-specific expression of the human norepinephrine transporter gene.
Kim CH; Kim HS; Cubells JF; Kim KS
J Biol Chem; 1999 Mar; 274(10):6507-18. PubMed ID: 10037744
[TBL] [Abstract][Full Text] [Related]
78. Tumor dosimetry using [124I]m-iodobenzylguanidine microPET/CT for [131I]m-iodobenzylguanidine treatment of neuroblastoma in a murine xenograft model.
Seo Y; Gustafson WC; Dannoon SF; Nekritz EA; Lee CL; Murphy ST; VanBrocklin HF; Hernandez-Pampaloni M; Haas-Kogan DA; Weiss WA; Matthay KK
Mol Imaging Biol; 2012 Dec; 14(6):735-42. PubMed ID: 22382618
[TBL] [Abstract][Full Text] [Related]
79. 131I-metaiodobenzylguanidine uptake in the isolated rat lung: a potential marker of endothelial cell function.
Slosman DO; Davidson D; Brill AB; Alderson PO
Eur J Nucl Med; 1988; 13(10):543-7. PubMed ID: 3371377
[TBL] [Abstract][Full Text] [Related]
80. Accumulation of m-iodobenzylguanidine by neuroblastoma cells results from independent uptake and storage mechanisms.
Montaldo PG; Lanciotti M; Casalaro A; Cornaglia-Ferraris P; Ponzoni M
Cancer Res; 1991 Aug; 51(16):4342-6. PubMed ID: 1868458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
